THERIVA BIOLOGICS INC (TOVX) Stock Price, Quote, News and Overview
NYSEARCA:TOVX - NYSE Arca - US87164U5083 - Common Stock - Currency: USD
TOVX Quote, Performance and Key Statistics
NYSEARCA:TOVX (2/21/2025, 8:04:00 PM)
1.55
-0.06 (-3.73%)
The current stock price of TOVX is 1.55 USD. In the past month the price increased by 13.14%. In the past year, price decreased by -86.67%.
TOVX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About TOVX
Company Profile
Theriva Biologics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Rockville, Maryland and currently employs 21 full-time employees. Theriva Biologics, Inc. is a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need. The company is advancing a new oncolytic adenovirus platform. Its candidates are VCN-01, SYN-004 (ribaxamase) and SYN-020. VCN-01 is an oncolytic adenovirus designed to replicate selectively and aggressively within tumor cells, and to degrade the tumor stroma barrier that serves as a significant physical and immunosuppressive barrier to cancer treatment. SYN-004 (ribaxamase) is designed to degrade certain commonly used intravenous beta-lactam antibiotics within the gastrointestinal (GI) tract to prevent microbiome damage. SYN-020 is a recombinant oral formulation of the enzyme intestinal alkaline phosphatase produced under current good manufacturing practice conditions and intended to treat both local GI and systemic diseases. Its research programs include VCN-11 Albumin Shield Technology and SYN-006, SYN-007, other oncolytic virus.
Company Info
THERIVA BIOLOGICS INC
9605 Medical Center Drive, Suite 270
Rockville MARYLAND US
Employees: 22
Company Website: https://therivabio.com/
Investor Relations: https://therivabio.com/investors/
Phone: 17343327800
THERIVA BIOLOGICS INC / TOVX FAQ
What is the stock price of THERIVA BIOLOGICS INC today?
The current stock price of TOVX is 1.55 USD. The price decreased by -3.73% in the last trading session.
What is the ticker symbol for THERIVA BIOLOGICS INC stock?
The exchange symbol of THERIVA BIOLOGICS INC is TOVX and it is listed on the NYSE Arca exchange.
On which exchange is TOVX stock listed?
TOVX stock is listed on the NYSE Arca exchange.
What is the price forecast or stock price prediction for THERIVA BIOLOGICS INC stock?
8 analysts have analysed TOVX and the average price target is 6.12 USD. This implies a price increase of 294.84% is expected in the next year compared to the current price of 1.55. Check the THERIVA BIOLOGICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is THERIVA BIOLOGICS INC worth?
THERIVA BIOLOGICS INC (TOVX) has a market capitalization of 4.31M USD. This makes TOVX a Nano Cap stock.
How many employees does THERIVA BIOLOGICS INC have?
THERIVA BIOLOGICS INC (TOVX) currently has 22 employees.
What are the support and resistance levels for THERIVA BIOLOGICS INC (TOVX) stock?
THERIVA BIOLOGICS INC (TOVX) has a support level at 1.33 and a resistance level at 1.6. Check the full technical report for a detailed analysis of TOVX support and resistance levels.
Should I buy THERIVA BIOLOGICS INC (TOVX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of TOVX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of TOVX, evaluating the profitability, health, valuation and growth aspects
- THERIVA BIOLOGICS INC (TOVX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- THERIVA BIOLOGICS INC (TOVX) Sales and EPS estimates to see what analysts future expectations are.
- THERIVA BIOLOGICS INC (TOVX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- THERIVA BIOLOGICS INC (TOVX) Insider and Institutional Ownership to learn about the owners and their transactions.
- THERIVA BIOLOGICS INC (TOVX) Stock Chart to make your own analysis
- THERIVA BIOLOGICS INC (TOVX) Latest news and press-releases to stay up to date.
Does THERIVA BIOLOGICS INC (TOVX) stock pay dividends?
TOVX does not pay a dividend.
When does THERIVA BIOLOGICS INC (TOVX) report earnings?
THERIVA BIOLOGICS INC (TOVX) will report earnings on 2025-03-24, after the market close.
What is the Price/Earnings (PE) ratio of THERIVA BIOLOGICS INC (TOVX)?
THERIVA BIOLOGICS INC (TOVX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-29.25).
What is the Short Interest ratio of THERIVA BIOLOGICS INC (TOVX) stock?
The outstanding short interest for THERIVA BIOLOGICS INC (TOVX) is 10.32% of its float. Check the ownership tab for more information on the TOVX short interest.
TOVX Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to TOVX. When comparing the yearly performance of all stocks, TOVX is a bad performer in the overall market: 91.41% of all stocks are doing better.
TOVX Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to TOVX. Both the profitability and financial health of TOVX have multiple concerns.
TOVX Financial Highlights
Over the last trailing twelve months TOVX reported a non-GAAP Earnings per Share(EPS) of -29.25. The EPS increased by 7.87% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -66.55% | ||
| ROE | -108.35% | ||
| Debt/Equity | 0 |
TOVX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to TOVX. The Buy consensus is the average rating of analysts ratings from 8 analysts.